Bladder Cancer Clinical Trial

Assessment of Supportive Care and Educational Needs to Guide Quality Care Improvements for Patients With Locally Advanced and Metastatic Bladder Cancer

Summary

The overall goal of this study is to facilitate care improvements for bladder cancer patients with locally advanced or metastatic disease by designing and evaluating a patient need assessment screening tool to be used, in the future, as standard screening measure. Adult individuals diagnosed with Stage 4 incurable locally advanced or metastatic bladder cancer will be included in this study and asked to participate in a focus group, complete a screening tool, or complete a survey. All data collected will be linked to a study ID number and HIPAA identifiers will not be linked to study data. Identifying information (ie: name, mrn, email, phone number) will be utilized for study recruitment and identifying eligible patients. Any disclosure of the human subjects' responses outside the research would not reasonably place the subjects at risk of criminal or civil liability or be damaging to the subjects' financial standing, employability, educational advancement, or reputation.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients are eligible to participate if they are diagnosed with Stage 4 incurable locally advanced or metastatic bladder cancer
between 18 years and older (18-89 years)
have initiated any systemic treatment for advanced urothelial carcinoma
speak English speaking and are able to consent.

Exclusion Criteria:

Have a diagnosis of another advanced cancer that has required systemic therapy
Or have any condition that, in the opinion of the investigator, would compromise the well- being of the subject or the study or prevent the subject from meeting or performing study requirements.

Study is for people with:

Bladder Cancer

Estimated Enrollment:

210

Study ID:

NCT06412874

Recruitment Status:

Recruiting

Sponsor:

Icahn School of Medicine at Mount Sinai

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Icahn School of Medicine at Mount Sinai
New York New York, 10029, United States More Info
Talia Korn, MA
Contact
305-610-5218
[email protected]
Nihal Mohamed, PhD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Bladder Cancer

Estimated Enrollment:

210

Study ID:

NCT06412874

Recruitment Status:

Recruiting

Sponsor:


Icahn School of Medicine at Mount Sinai

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.